|
|
 |
|
Viewing report
|
|
|
|
Pharmaceutical Industry in China
Taiyou Research, Nov 2011, Pages: 240
China has one of the world's top ten largest pharmaceutical markets. The pharmaceutical industry in China is a booming sector as it covers not only pharmaceutical drugs, but also synthetic chemicals and drugs, prepared Chinese medicines, medical devices, apparatus and instruments, hygiene materials, packing materials, and pharmaceutical machinery. China's pharmaceutical market has experienced significant growth in recent years, fueled by increasing wealth among its own population as well as the accelerating global demand for cheap, effective medicines to treat ailments ranging from high cholesterol to HIV/AIDS.
Yet, the country is plagued by worrying incidents, in some cases deadly ones, of poor drug quality. While these pharmaceutical production problems are not exclusive to China, they have tarnished its reputation abroad. Fears have been exacerbated by Beijing's failure to acknowledge quality shortcomings quickly. Most exports to wealthy industrialized countries which are monitored by pharmaceutical manufacturers policing their own supply chains and by strict drug regulatory authorities appear to be of high quality. However, data collected by European Union customs officials also show that China is among the world's top four exporters of counterfeit pharmaceuticals. Fears over intellectual property protection also plague the Chinese pharmaceutical industry.
However, with the sweeping reforms carried out by the Chinese government in a bid to ease international fears about its pharmaceutical and healthcare industries, the industry is undergoing significant change, as well as looking at major changes in the coming years.
Top players in the Chinese pharmaceutical industry by far remain China National Pharmaceutical Group Corp (Sinopharm), Shijiazhuang Pharma Group, Wuxi Pharmatech, Harbin Pharmaceutical Group Co., amongst other multinational players. Many foreign players such as AstraZeneca, Pfizer Inc, Bayer, GSK, etc., have already established themselves firmly in the market and are expanding their services regularly within the country. With the entry of foreign players in the industry, the competition amongst players has significantly been stepped up, along with the quality of pharmaceutical manufacturing processes.
The increase of disposable income, the elevation of urbanization level and the country's aging population are all factors boosting China's pharmaceutical industry in the near future. With China being a major outsourcing hub for the global pharmaceutical industry, there is no doubt that the future of the Chinese pharmaceutical industry holds substantial growth potential as well.
In this industry scenario, Taiyou Research analyzes the Pharmaceutical Industry in China. The report covers the following:
- Overview of the Chinese pharmaceutical industry containing an industry definition, market statistics, market value, industry segments and structure, and an industry value chain analysis. The value chain analysis looks at the industry through raw material manufacturers, pharma companies, drug distribution companies, medical service providers, and buyers of healthcare.
- Market analysis section is an in-depth analysis of the industry. This includes a market profile, growth profile of the market for the OTC market, market for prescription drugs, and the generics market. Healthcare reforms that have recently been changing the industry landscape are analyzed. Unstable and fragment distribution channels of the industry, the pharmaceutical sales channels, and the expansion and consolidation of pharmacies in China are all analyzed in this section.
Following on from an analysis of the healthcare reforms in China, Taiyou Research analyze the regulatory framework.
- The section on regulatory framework looks at industry regulations, regulatory agencies, challenge of IP protection in China along with the challenge of counterfeit medicines. The implementation of pricing controls and price cuts are analyzed. The drug reimbursement regime and GMP compliance certification are looked at. Taiyou Research also carry out a comparison between the pharma regulations in China versus other countries.
- Industry trends and opportunities are analyzed keeping in mind the trends in the healthcare sector, trends in the hospital sector, as well as the high level of competition amongst players in the industry. Mergers and acquisitions and the entry of foreign multinationals in the industry are also analyzed.
- Research and development in the industry, clinical trials in China, and the market for Active Pharmaceutical Ingredients (APIs) are also analyzed in this report, along with a look at the Chinese vaccines market.
Moving on to framework analyses, Taiyou Research analyze the Chinese Pharmaceutical Industry in a SWOT analysis, a PEST analysis, and a Porter's Five Forces analysis.
- An analysis of the generic drug sector in China, biotechnology sector, as well as the ever-prominent traditional Chinese medicine (TCM) sector is included in the report.
- Taiyou Research also carry out an analysis of the medical devices market in China, complete with a market profile, growth drivers, and value chain analysis.
- Competition in the industry is of course fierce, and Taiyou Research dedicate an in-depth section on analyzing the same. The report contains an overall industry competitive profile, the market view of competition, the increasing role of multinationals in the industry along with an analysis of the major strategies of some major foreign players in China. Competition amongst domestic players and amongst pharma companies venturing into biotechnology are also analyzed. With TCM making up a substantial chunk of the market, Taiyou Research take a look at the competition from Traditional Chinese Medicines as well as the competition in the generics market.
- Major industry players are analyzed in two segments - leading domestic companies and leading multinational companies.
An in-depth industry forecast completes this comprehensive and cutting-edge report on the Pharmaceutical Industry in China.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
